Antidepressant-induced sweating alleviated by aripiprazole.
Lu
Brett Y
BY
Cullen
Chandra E
CE
Eide
Carla E
CE
Williams
Cynthia C
CC
Apfeldorf
William J
WJ
D000928:Antidepressive Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000068180:Aripiprazole; D018491:Dopamine Agonists / Q000627:therapeutic use*; D000068736:Duloxetine Hydrochloride; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D006945:Hyperhidrosis / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*; D013546:Sweating / Q000187:drug effects*; D013876:Thiophenes / Q000009:adverse effects*
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D010879:Piperazines; D015363:Quinolones; D013876:Thiophenes; D005473:Fluoxetine; D000068180:Aripiprazole; D000068736:Duloxetine Hydrochloride